Phase 2 Lung Cancer Trial, Recruiting (NCT06758700)

Phase 2 Lung Cancer Trial, Recruiting NCT06758700 Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06758700 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People diagnosed with extensive stage small cell lung cancer (a type of lung cancer that has spread widely)
People whose cancer has continued to grow or come back after receiving at least one chemotherapy treatment in the past
People with a performance status score of 0 or 1 on the ECOG scale, meaning they are fully active or able to carry out light activities (confirm with trial site)
People whose cancer is driven by a specific protein called c-Myc (confirm with trial site how this is tested)
People whose doctors expect them to live for at least 3 months or longer
People aged between 18 and 75 years old
People who are able to provide informed consent in line with international clinical research principles

Who may not be able to join:

People who do not have any measurable areas of cancer that can be tracked during the trial
People who have other serious or ongoing illnesses, or significant problems with how their organs are functioning
Women who are planning to become pregnant, or men who are planning to father a child during the trial period
Women who are currently pregnant or breastfeeding
People who are unable or unwilling to follow the study procedures set out by the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 21 65115006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06758700

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Phase: Phase 2

Status: Recruiting

Condition: Lung Cancer

Trial contact: +86 21 65115006

More information: https://clinicaltrials.gov/study/NCT06758700

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People diagnosed with extensive stage small cell lung cancer (a type of lung cancer that has spread widely)
People whose cancer has continued to grow or come back after receiving at least one chemotherapy treatment in the past
People with a performance status score of 0 or 1 on the ECOG scale, meaning they are fully active or able to carry out light activities (confirm with trial site)
People whose cancer is driven by a specific protein called c-Myc (confirm with trial site how this is tested)
People whose doctors expect them to live for at least 3 months or longer
People aged between 18 and 75 years old
People who are able to provide informed consent in line with international clinical research principles

Who may not be able to join:

People who do not have any measurable areas of cancer that can be tracked during the trial
People who have other serious or ongoing illnesses, or significant problems with how their organs are functioning
Women who are planning to become pregnant, or men who are planning to father a child during the trial period
Women who are currently pregnant or breastfeeding
People who are unable or unwilling to follow the study procedures set out by the research team

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Registry

ClinicalTrials.gov

Start date

7 February 2025

Est. completion

30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective Response Rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov